Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
China
· Delayed Price · Currency is CNY 29.88
-0.13 (-0.43%)
Nov 21, 2024, 3:00 PM CST
Hubei Jumpcan Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 27,541 | 28,972 | 25,092 | 25,173 | 17,969 | 19,705 | Upgrade
|
| Market Cap Growth | 14.52% | 15.46% | -0.32% | 40.09% | -8.81% | -27.88% | Upgrade
|
| Enterprise Value | 17,090 | 19,711 | 18,865 | 20,556 | 14,633 | 18,236 | Upgrade
|
| Last Close Price | 29.88 | 30.31 | 25.46 | 25.74 | 17.94 | 20.28 | Upgrade
|
| PE Ratio | 9.87 | 10.26 | 11.56 | 14.64 | 14.07 | 12.14 | Upgrade
|
| Forward PE | 9.58 | 11.02 | 11.16 | 13.64 | 11.87 | 8.60 | Upgrade
|
| PS Ratio | 3.08 | 3.00 | 2.79 | 3.30 | 2.91 | 2.84 | Upgrade
|
| PB Ratio | 1.94 | 2.17 | 2.21 | 2.76 | 2.31 | 3.23 | Upgrade
|
| P/TBV Ratio | 2.12 | 2.25 | 2.31 | 2.90 | 2.46 | 3.52 | Upgrade
|
| P/FCF Ratio | 12.89 | 9.16 | 10.56 | 15.29 | 13.29 | 12.31 | Upgrade
|
| P/OCF Ratio | 12.32 | 8.36 | 9.57 | 13.29 | 10.09 | 9.17 | Upgrade
|
| EV/Sales Ratio | 1.92 | 2.04 | 2.10 | 2.69 | 2.37 | 2.63 | Upgrade
|
| EV/EBITDA Ratio | 5.68 | 6.20 | 7.37 | 10.47 | 8.78 | 8.96 | Upgrade
|
| EV/EBIT Ratio | 6.29 | 6.84 | 8.37 | 12.30 | 10.56 | 10.12 | Upgrade
|
| EV/FCF Ratio | 8.00 | 6.23 | 7.94 | 12.49 | 10.82 | 11.39 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.08 | 0.04 | 0.07 | 0.08 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.41 | 0.34 | 0.16 | 0.32 | 0.36 | 0.28 | Upgrade
|
| Debt / FCF Ratio | 0.57 | 0.34 | 0.17 | 0.38 | 0.45 | 0.36 | Upgrade
|
| Asset Turnover | 0.51 | 0.58 | 0.66 | 0.67 | 0.64 | 0.84 | Upgrade
|
| Inventory Turnover | 2.86 | 4.05 | 4.01 | 3.90 | 3.66 | 3.38 | Upgrade
|
| Quick Ratio | 3.54 | 2.99 | 3.13 | 2.75 | 3.18 | 2.47 | Upgrade
|
| Current Ratio | 3.72 | 3.10 | 3.26 | 2.90 | 3.34 | 2.67 | Upgrade
|
| Return on Equity (ROE) | 20.97% | 22.87% | 21.20% | 20.33% | 18.42% | 28.07% | Upgrade
|
| Return on Assets (ROA) | 9.78% | 10.88% | 10.39% | 9.22% | 9.03% | 13.69% | Upgrade
|
| Return on Capital (ROIC) | 11.86% | 13.75% | 13.10% | 11.52% | 11.51% | 17.75% | Upgrade
|
| Earnings Yield | 10.13% | 9.74% | 8.65% | 6.83% | 7.11% | 8.24% | Upgrade
|
| FCF Yield | 7.76% | 10.91% | 9.47% | 6.54% | 7.52% | 8.13% | Upgrade
|
| Dividend Yield | 4.33% | 4.29% | 3.46% | 2.64% | 2.51% | 6.07% | Upgrade
|
| Payout Ratio | 43.91% | 29.16% | 27.89% | 23.81% | 78.98% | 61.94% | Upgrade
|
| Buyback Yield / Dilution | 0.20% | -0.91% | -0.91% | -7.82% | -2.36% | -0.02% | Upgrade
|
| Total Shareholder Return | 4.53% | 3.38% | 2.55% | -5.18% | 0.15% | 6.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.